181 related articles for article (PubMed ID: 24086340)
21. p62/SQSTM1 levels predicts radiotherapy resistance in hypopharyngeal carcinomas.
Arai A; Chano T; Ikebuchi K; Hama Y; Ochi Y; Tameno H; Shimada T
Am J Cancer Res; 2017; 7(4):881-891. PubMed ID: 28469960
[TBL] [Abstract][Full Text] [Related]
22. p62 at the interface of autophagy, oxidative stress signaling, and cancer.
Nezis IP; Stenmark H
Antioxid Redox Signal; 2012 Sep; 17(5):786-93. PubMed ID: 22074114
[TBL] [Abstract][Full Text] [Related]
23. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma.
Tseng YK; Chen CF; Shu CW; Lee CH; Chou YT; Li YJ; Liou HH; Cheng JT; Chen CL; Ger LP; Liu PF
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830108
[TBL] [Abstract][Full Text] [Related]
24. P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex.
Garufi A; Giorno E; Gilardini Montani MS; Pistritto G; Crispini A; Cirone M; D'Orazi G
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669070
[TBL] [Abstract][Full Text] [Related]
25. Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells.
Zhang YB; Gong JL; Xing TY; Zheng SP; Ding W
Cell Death Dis; 2013 Mar; 4(3):e550. PubMed ID: 23519119
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.
Myeku N; Figueiredo-Pereira ME
J Biol Chem; 2011 Jun; 286(25):22426-40. PubMed ID: 21536669
[TBL] [Abstract][Full Text] [Related]
27. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.
Katsuragi Y; Ichimura Y; Komatsu M
FEBS J; 2015 Dec; 282(24):4672-8. PubMed ID: 26432171
[TBL] [Abstract][Full Text] [Related]
28. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
29. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response.
Yang Y; Willis TL; Button RW; Strang CJ; Fu Y; Wen X; Grayson PRC; Evans T; Sipthorpe RJ; Roberts SL; Hu B; Zhang J; Lu B; Luo S
Nat Commun; 2019 Aug; 10(1):3759. PubMed ID: 31434890
[TBL] [Abstract][Full Text] [Related]
31. p62/SQSTM1 is involved in caspase-8 associated cell death induced by proteasome inhibitor MG132 in U87MG cells.
Zeng RX; Zhang YB; Fan Y; Wu GL
Cell Biol Int; 2014 Oct; 38(10):1221-6. PubMed ID: 24805111
[TBL] [Abstract][Full Text] [Related]
32. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T; Ichimura Y; Taguchi K; Suzuki T; Mizushima T; Takagi K; Hirose Y; Nagahashi M; Iso T; Fukutomi T; Ohishi M; Endo K; Uemura T; Nishito Y; Okuda S; Obata M; Kouno T; Imamura R; Tada Y; Obata R; Yasuda D; Takahashi K; Fujimura T; Pi J; Lee MS; Ueno T; Ohe T; Mashino T; Wakai T; Kojima H; Okabe T; Nagano T; Motohashi H; Waguri S; Soga T; Yamamoto M; Tanaka K; Komatsu M
Nat Commun; 2016 Jun; 7():12030. PubMed ID: 27345495
[TBL] [Abstract][Full Text] [Related]
33. Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.
Riz I; Hawley TS; Marsal JW; Hawley RG
Oncotarget; 2016 Oct; 7(41):66360-66385. PubMed ID: 27626179
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA
Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274
[TBL] [Abstract][Full Text] [Related]
35. Tissue specific induction of p62/Sqstm1 by farnesoid X receptor.
Williams JA; Thomas AM; Li G; Kong B; Zhan L; Inaba Y; Xie W; Ding WX; Guo GL
PLoS One; 2012; 7(8):e43961. PubMed ID: 22952826
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
37. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
38. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.
Puvirajesinghe TM; Bertucci F; Jain A; Scerbo P; Belotti E; Audebert S; Sebbagh M; Lopez M; Brech A; Finetti P; Charafe-Jauffret E; Chaffanet M; Castellano R; Restouin A; Marchetto S; Collette Y; Gonçalvès A; Macara I; Birnbaum D; Kodjabachian L; Johansen T; Borg JP
Nat Commun; 2016 Jan; 7():10318. PubMed ID: 26754771
[TBL] [Abstract][Full Text] [Related]
39. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.
Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD
Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418
[TBL] [Abstract][Full Text] [Related]
40. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
